Endava (DAVA)
(Delayed Data from NYSE)
$23.71 USD
+0.06 (0.25%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $23.71 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$23.71 USD
+0.06 (0.25%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $23.71 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
Zacks News
Endava PLC Sponsored ADR (DAVA) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Endava (DAVA) delivered earnings and revenue surprises of -3.45% and 1.35%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Endava PLC Sponsored ADR (DAVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Endava (DAVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Methode (MEI) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Methode (MEI) delivered earnings and revenue surprises of -10.71% and 3.42%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
C3.ai, Inc. (AI) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
C3.ai (AI) delivered earnings and revenue surprises of 61.54% and 0.11%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Endava (DAVA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Endava (DAVA) stock based on the movements in the options market lately.
Endava PLC Sponsored ADR (DAVA) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Endava (DAVA) delivered earnings and revenue surprises of 21.74% and 0.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Endava PLC Sponsored ADR (DAVA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Endava (DAVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CDW (CDW) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
CDW (CDW) delivered earnings and revenue surprises of -11.11% and 1.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for March 8th
by Zacks Equity Research
DAVA, KOS and LVRO have been added to the Zacks Rank #5 (Strong Sell) List on March 8, 2023.
CDW (CDW) Q4 Earnings Meet Estimates
by Zacks Equity Research
CDW (CDW) delivered earnings and revenue surprises of 0% and 6.35%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Endava PLC Sponsored ADR (DAVA) Surges 6.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Epam (EPAM) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Epam (EPAM) delivered earnings and revenue surprises of 6.64% and 0.67%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Endava PLC Sponsored ADR (DAVA) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) delivered earnings and revenue surprises of 26.79% and 0.20%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
SAIC (SAIC) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
SAIC (SAIC) delivered earnings and revenue surprises of 28.12% and 5.43%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?
C3.ai, Inc. (AI) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
C3.ai, Inc. (AI) delivered earnings and revenue surprises of 47.06% and 14.14%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?
Endava (DAVA) Continues Expansion With the Acquisition of DEK
by Zacks Equity Research
Endava (DAVA) expands its presence in the Asia Pacific region with the acquisition of DEK.
2 Top-Rated Foreign Tech Stocks to Buy After Earnings
by Shaun Pruitt
Endava (DAVA) and Vipshop (VIPS) are worthy of investors' consideration as they offer foreign exposure to strong business industries at the moment.
Endava PLC Sponsored ADR (DAVA) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) delivered earnings and revenue surprises of 10.77% and 5.78%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
CyberArk (CYBR) Soars 5.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
CyberArk (CYBR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Do Options Traders Know Something About Endava (DAVA) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Endava (DAVA) stock based on the movements in the options market lately.
What's in Store for Applied Materials (AMAT) in Q1 Earnings?
by Zacks Equity Research
Applied Materials' (AMAT) first-quarter fiscal 2023 earnings are expected to have been aided by solid momentum across the Semiconductor Systems Group and AGS segments.
Analog Devices (ADI) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Analog Devices' (ADI) results for the fiscal first quarter are likely to reflect strength across the automotive, industrial, communication and consumer markets amid macro headwinds.
Waters (WAT) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Waters' (WAT) fourth-quarter 2022 results are likely to reflect strength in liquid chromatography instruments and mass spectrometers, and solid end-market momentum.
Endava PLC Sponsored ADR (DAVA) Q2 Earnings Lag Estimates
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) delivered earnings and revenue surprises of -1.47% and 1.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Endava (DAVA)
by Zacks Equity Research
Endava (DAVA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.